search
Back to results

Efficacy of Doll Therapy in the Dementia in Acute Geriatric Inpatients (AGITATE)

Primary Purpose

Dementia

Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
doll therapy
Sponsored by
Centre Hospitalier Universitaire Vaudois
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Dementia

Eligibility Criteria

65 Years - undefined (Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: age ≥65 years diagnosis of dementia moderate to severe Clinical Dementia Rating scale (CDR) ≥2 presence of agitation and/or aggressiveness manual and visual abilities sufficient in order to interact with the doll. Exclusion Criteria: age <65 years; refuse to participate; mild forms of dementia (CDR<2); contraindication for DT as experience of mournful or traumatic events related to parental experience; life expectancy lower than 3 months; infectious diseases requiring isolation; negative interaction with the doll, presence of delirium.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    Other

    Arm Label

    doll therapy

    non anthropomorphic object

    Arm Description

    The doll used in the study is the "empathy doll"; these dolls are designed to obtain an optimal interaction with patients and to arouse empathy

    non- anthropomorphic soft object

    Outcomes

    Primary Outcome Measures

    agitation and aggressiveness within hospital
    measured by Pittsburgh Agitation Scale (PAS). the score ranges between 0 to 16 on the PAS the higher score means the higher agitation
    behavioural and psychological symptoms of dementia
    Neuro Psychiatic Inventory (NPI). The NPI total score ranges from 0 to 144, higher scores means more severe and frequent behavioural and psycological symptoms of dementia
    agitation and aggressiveness outside hospital
    Cohen Mansfield Inventory scale (CMAI). the score ranges betwen 0 and 203, with higher scores indicating more agitation

    Secondary Outcome Measures

    incidence of delirium
    measured by the Confusion Assessment Method (CAM) scale. For a diagnosis of delirium by CAM, the patient must display: Presence of acute onset and fluctuating discourse AND Inattention AND EITHER Disorganized thinking OR Altered level of consciousness
    patients' quality of life
    by the use of the AD-5D Dementia Utility Instrument, the scales scores between -1 to 1, the highest score indicate the better quality of life
    family caregivers' quality of life
    by the EuroQoL 5-Dimensions 5 level versions. the scale scores from 5 to 25 the highest the score the lowest the quality of life
    professional caregiver burden
    Staff Stress Measure Dementia Care (SSMDC). The scale comprised the following 27 items producing a five-factor solution: Frustrated empathy; difficulties understanding and interpreting; balancing competing needs; balancing emotional involvement; and lack of recognition.
    family caregiver burden
    Caregiver Burden Inventory (CBI) scale. The Caregiver Burden Inventory comprises 24 closed questions divided into five dimensions: time-dependence, developmental, physical, social and emotional burden. There are five items in each dimension except for physical burden, which has four items dedicated to. Each item is given a score between 0 (not at all descriptive) and 4 (very descriptive), where higher scores indicate greater caregiver burden; there are no cut-off points for classifying burden. Therefore, total scores for factors one, two, four and five can range from zero to 20. An equivalent score for physical burden can be obtained by multiplying the sum of items in this dimension by 1.25

    Full Information

    First Posted
    November 29, 2022
    Last Updated
    April 5, 2023
    Sponsor
    Centre Hospitalier Universitaire Vaudois
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT05691569
    Brief Title
    Efficacy of Doll Therapy in the Dementia in Acute Geriatric Inpatients
    Acronym
    AGITATE
    Official Title
    Efficacy of Doll Therapy in the Control of Behavioral and psychologIcal Symptoms of Dementia in Acute Geriatric Inpatients: the AGITATE Study.
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    April 2023
    Overall Recruitment Status
    Not yet recruiting
    Study Start Date
    September 2023 (Anticipated)
    Primary Completion Date
    December 30, 2025 (Anticipated)
    Study Completion Date
    May 31, 2026 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Centre Hospitalier Universitaire Vaudois

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    Summary. Behavioral and psychological symptoms of dementia (BPSD) represents a huge emotional stress and an important burden for the patients and the caregivers severely reducing their quality of life. BPSD worsen during hospitalization and require the administration of psychotropic drugs that are often insufficient to control the symptoms, and may cause severe adverse events. The investigators propose the use of empathy dolls in order to reduce BPSD and in particular agitation and aggressiveness in acute geriatric in-patients affected by moderate to severe forms of dementia. The use of doll therapy in the clinical routine will allow to reduce the use of psychotropic drugs, shorten hospitalization, reduce professional and family caregiver burden improving patients' and families' quality of life.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Dementia

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Model Description
    This is a randomized controlled open label trial with two parallel arms
    Masking
    None (Open Label)
    Allocation
    Randomized
    Enrollment
    92 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    doll therapy
    Arm Type
    Experimental
    Arm Description
    The doll used in the study is the "empathy doll"; these dolls are designed to obtain an optimal interaction with patients and to arouse empathy
    Arm Title
    non anthropomorphic object
    Arm Type
    Other
    Arm Description
    non- anthropomorphic soft object
    Intervention Type
    Other
    Intervention Name(s)
    doll therapy
    Intervention Description
    empathy dolls
    Primary Outcome Measure Information:
    Title
    agitation and aggressiveness within hospital
    Description
    measured by Pittsburgh Agitation Scale (PAS). the score ranges between 0 to 16 on the PAS the higher score means the higher agitation
    Time Frame
    baseline and hospital discharge discharge (up to one week)
    Title
    behavioural and psychological symptoms of dementia
    Description
    Neuro Psychiatic Inventory (NPI). The NPI total score ranges from 0 to 144, higher scores means more severe and frequent behavioural and psycological symptoms of dementia
    Time Frame
    baseline, discharge (up to one week)
    Title
    agitation and aggressiveness outside hospital
    Description
    Cohen Mansfield Inventory scale (CMAI). the score ranges betwen 0 and 203, with higher scores indicating more agitation
    Time Frame
    baseline, 1 and 4 weeks after discharge
    Secondary Outcome Measure Information:
    Title
    incidence of delirium
    Description
    measured by the Confusion Assessment Method (CAM) scale. For a diagnosis of delirium by CAM, the patient must display: Presence of acute onset and fluctuating discourse AND Inattention AND EITHER Disorganized thinking OR Altered level of consciousness
    Time Frame
    every day during hospital stay (up to one week)
    Title
    patients' quality of life
    Description
    by the use of the AD-5D Dementia Utility Instrument, the scales scores between -1 to 1, the highest score indicate the better quality of life
    Time Frame
    baseline and 4 weeks after discharge
    Title
    family caregivers' quality of life
    Description
    by the EuroQoL 5-Dimensions 5 level versions. the scale scores from 5 to 25 the highest the score the lowest the quality of life
    Time Frame
    baseline and 4 weeks after discharge
    Title
    professional caregiver burden
    Description
    Staff Stress Measure Dementia Care (SSMDC). The scale comprised the following 27 items producing a five-factor solution: Frustrated empathy; difficulties understanding and interpreting; balancing competing needs; balancing emotional involvement; and lack of recognition.
    Time Frame
    baseline and at hospital discharge (up to one week)
    Title
    family caregiver burden
    Description
    Caregiver Burden Inventory (CBI) scale. The Caregiver Burden Inventory comprises 24 closed questions divided into five dimensions: time-dependence, developmental, physical, social and emotional burden. There are five items in each dimension except for physical burden, which has four items dedicated to. Each item is given a score between 0 (not at all descriptive) and 4 (very descriptive), where higher scores indicate greater caregiver burden; there are no cut-off points for classifying burden. Therefore, total scores for factors one, two, four and five can range from zero to 20. An equivalent score for physical burden can be obtained by multiplying the sum of items in this dimension by 1.25
    Time Frame
    baseline and 4 weeks after discharge

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    65 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: age ≥65 years diagnosis of dementia moderate to severe Clinical Dementia Rating scale (CDR) ≥2 presence of agitation and/or aggressiveness manual and visual abilities sufficient in order to interact with the doll. Exclusion Criteria: age <65 years; refuse to participate; mild forms of dementia (CDR<2); contraindication for DT as experience of mournful or traumatic events related to parental experience; life expectancy lower than 3 months; infectious diseases requiring isolation; negative interaction with the doll, presence of delirium.

    12. IPD Sharing Statement

    Plan to Share IPD
    No
    Citations:
    PubMed Identifier
    34641791
    Citation
    Santagata F, Massaia M, D'Amelio P. The doll therapy as a first line treatment for behavioral and psychologic symptoms of dementia in nursing homes residents: a randomized, controlled study. BMC Geriatr. 2021 Oct 12;21(1):545. doi: 10.1186/s12877-021-02496-0.
    Results Reference
    background

    Learn more about this trial

    Efficacy of Doll Therapy in the Dementia in Acute Geriatric Inpatients

    We'll reach out to this number within 24 hrs